# Rapport Therapeutics

> Rapport Therapeutics, Inc. (Nasdaq: RAPP) is a clinical-stage biotechnology company in Boston, MA
> and San Diego, CA, developing precision small-molecule medicines for central nervous system
> disorders on its RAP technology platform. Rapport publishes no developer program, no public API and
> no machine-readable API contract; this file exists so agents can find the company's authoritative
> public pages and stop looking for an API surface that does not exist.

## APIs

- None. Rapport Therapeutics is a therapeutics developer, not a software vendor. As of 2026-08-26 no
  OpenAPI, Swagger, GraphQL, AsyncAPI, gRPC or WSDL contract is published on any Rapport host, and no
  developer, docs or api subdomain resolves.

## Company

- [Home](https://www.rapportrx.com/): Precision medicines to match the complexity of the human brain.
- [About Us](https://www.rapportrx.com/about/): Company overview.
- [Leadership Team](https://www.rapportrx.com/about/leadership/)
- [Board of Directors](https://www.rapportrx.com/about/board-of-directors/)
- [Scientific Advisory Board](https://www.rapportrx.com/about/scientific-advisory-board/)
- [Careers](https://www.rapportrx.com/join-us/)
- [Contact](https://www.rapportrx.com/contact/)

## Science and Pipeline

- [Precision Neuroscience](https://www.rapportrx.com/precision-neuroscience/): The RAP technology
  platform — receptor-associated proteins that confer neuroanatomical specificity.
- [Pipeline](https://www.rapportrx.com/pipeline/): RAP-219 (TARP-gamma-8 negative allosteric
  modulator) in focal onset seizures, peripheral neuropathic pain and bipolar disorder; discovery
  programs on alpha-6 nAChR (chronic pain) and alpha-9-alpha-10 nAChR (hearing disorders).
- [Programs](https://www.rapportrx.com/programs/)
- [Publications](https://www.rapportrx.com/precision-neuroscience/publications/)
- [Scientific and Medical Meetings](https://www.rapportrx.com/precision-neuroscience/scientific-and-medical-meetings/)

## News and Investors

- [Press release and publication feed (RSS)](https://www.rapportrx.com/feed/)
- Investor relations is hosted off-site at investors.rapportrx.com (CNAME rapportrx.gcs-web.com).
  That host refused connections from this client on 2026-08-26 and is therefore not linked here as a
  verified URL.

## Policies

- [Privacy Policy](https://www.rapportrx.com/privacy-policy/)
- [Terms of Use](https://www.rapportrx.com/terms-of-use/)
- [Expanded Access Policy](https://www.rapportrx.com/expanded-access-policy/)
- [Accessibility Statement](https://www.rapportrx.com/accessibility-statement/)

## Machine-readable surfaces that exist but are not APIs

- [XML Sitemap index](https://www.rapportrx.com/sitemap_index.xml): Yoast SEO sitemap, 17 pages and
  35 posts.
- /wp-json/ returns the WordPress core REST API index (HTTP 200, ~262 KB, browser User-Agent
  required; a default User-Agent gets HTTP 403). This is the CMS default, unadvertised anywhere on
  the site and describing pages and posts rather than a product. It is recorded here as an observed
  fact and is deliberately NOT catalogued as a Rapport Therapeutics API.
- No /llms.txt is served by the provider (HTTP 404 on 2026-08-26). This file was generated by the API
  Evangelist enrichment pipeline from the company's own public pages.

## API Evangelist artifacts in this repo

- [apis.yml](https://raw.githubusercontent.com/api-evangelist/rapport-therapeutics/refs/heads/main/apis.yml)
- [Domain security probe](https://raw.githubusercontent.com/api-evangelist/rapport-therapeutics/refs/heads/main/security/rapport-therapeutics-domain-security.yml)
- [Well-known probe](https://raw.githubusercontent.com/api-evangelist/rapport-therapeutics/refs/heads/main/well-known/rapport-therapeutics-well-known.yml)